WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	85,270	113,802	92,943	128,366	123,616	138,481
Market Cap Growth	-13.07%	22.44%	-27.59%	3.84%	-10.73%	-26.91%
Enterprise Value	85,112	114,670	101,308	130,632	113,324	119,353
Last Close Price	6460.00	8620.00	7040.00	9730.00	9270.64	10388.65

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	11.70	22.91	19.43	16.13	49.86	32.48
PS Ratio	0.78	1.07	0.91	1.60	1.91	2.41
PB Ratio	0.84	1.16	1.00	1.42	1.49	1.71
P/TBV Ratio	0.88	1.22	1.05	1.46	1.54	1.75
P/FCF Ratio	26.25	20.76	12.79	-	-	102.25
P/OCF Ratio	11.05	16.78	9.65	-	22.98	17.27

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.78	1.08	0.99	1.63	1.75	2.08
EV/EBITDA Ratio	10.64	11.77	10.73	12.15	16.60	18.69
EV/EBIT Ratio	22.24	20.25	17.90	16.52	23.23	24.43
EV/FCF Ratio	26.20	20.91	13.94	-	-	88.13

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.21	0.19	0.26	0.22	0.26	0.29
Debt / EBITDA Ratio	2.64	1.92	2.55	1.86	3.14	3.62
Debt / FCF Ratio	6.49	3.42	3.31	-	-	17.06
Net Debt / Equity Ratio	0.00	-0.01	0.06	0.10	-0.06	-0.24
Net Debt / EBITDA Ratio	-0.02	-0.07	0.55	0.82	-0.75	-3.03
Net Debt / FCF Ratio	-0.05	-0.13	0.71	-0.73	0.51	-14.30
Asset Turnover	0.79	0.79	0.77	0.64	0.54	0.51
Inventory Turnover	2.23	2.14	2.31	2.52	3.07	2.98
Quick Ratio	1.36	1.37	1.21	1.20	1.74	2.55
Current Ratio	2.00	2.06	1.80	1.88	2.33	3.19
Return on Equity (ROE)	7.41%	5.20%	5.22%	9.19%	3.02%	5.41%
Return on Assets (ROA)	1.74%	2.61%	2.67%	3.95%	2.56%	2.71%
Return on Invested Capital (ROIC)	3.84%	5.79%	5.34%	7.78%	4.17%	6.84%
Return on Capital Employed (ROCE)	3.50%	5.50%	5.60%	7.90%	5.20%	5.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	8.55%	4.37%	5.15%	6.20%	2.01%	3.08%
FCF Yield	3.81%	4.82%	7.82%	-9.38%	-8.05%	0.98%
Payout Ratio	-	-	27.57%	-	25.53%	9.90%
Buyback Yield / Dilution	0.04%	0.14%	-0.14%	-0.09%	0.10%	-59.55%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error